123 related articles for article (PubMed ID: 32157988)
1. Community perceptions of barriers to management of chronic psychotic disorders and knowledge and attitudes about long-acting injectable antipsychotic medication: qualitative study in Dar es Salaam, Tanzania.
Blixen C; Lema I; Mbwambo J; Kaaya S; Levin JB; Sajatovic M
BJPsych Open; 2020 Mar; 6(2):e27. PubMed ID: 32157988
[TBL] [Abstract][Full Text] [Related]
2. A customized adherence enhancement program combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania: A pilot study methodological report.
Mbwambo J; Kaaya S; Lema I; Blixen C; Cassidy KA; Levin JB; Sajatovic M
Heliyon; 2019 Jun; 5(6):e01763. PubMed ID: 31198864
[TBL] [Abstract][Full Text] [Related]
3. An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
Mbwambo J; Kaaya S; Lema I; Burant CJ; Magwiza C; Madundo K; Njiro G; Blixen CE; Cassidy KA; Levin JB; Sajatovic M
BMC Psychiatry; 2022 Jan; 22(1):62. PubMed ID: 35086504
[TBL] [Abstract][Full Text] [Related]
4. Risk and protective factors for relapse among individuals with schizophrenia: a qualitative study in Dar es Salaam, Tanzania.
Sariah AE; Outwater AH; Malima KI
BMC Psychiatry; 2014 Aug; 14():240. PubMed ID: 25168715
[TBL] [Abstract][Full Text] [Related]
5. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
[TBL] [Abstract][Full Text] [Related]
7. Medication challenges for patients with severe mental illness: experience and views of patients, caregivers and mental health care workers in Dar es Salaam, Tanzania.
Iseselo MK; Ambikile JS
Int J Ment Health Syst; 2017; 11():17. PubMed ID: 28184242
[TBL] [Abstract][Full Text] [Related]
8. Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania.
Edward A; Campbell B; Manase F; Appel LJ
BMC Health Serv Res; 2021 Aug; 21(1):834. PubMed ID: 34407820
[TBL] [Abstract][Full Text] [Related]
9. Alcohol use in Tanzanians with chronic psychotic disorders and poor medication adherence.
Simon E; Levin JB; Mbwambo J; Blixen C; Lema I; Aebi M; Njiro G; Cassidy K; Kaaya S; Sajatovic M
S Afr J Psychiatr; 2021; 27():1570. PubMed ID: 33824753
[TBL] [Abstract][Full Text] [Related]
10. Delayed diagnostic evaluation of symptomatic breast cancer in sub-Saharan Africa: A qualitative study of Tanzanian women.
Sakafu LL; Philipo GS; Malichewe CV; Fundikira LS; Lwakatare FA; Van Loon K; Mushi BP; DeBoer RJ; Bialous SA; Lee AY
PLoS One; 2022; 17(10):e0275639. PubMed ID: 36201503
[TBL] [Abstract][Full Text] [Related]
11. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
[TBL] [Abstract][Full Text] [Related]
12. Barriers to diabetic self-care: A qualitative study of patients' and healthcare providers' perspectives.
Mogre V; Johnson NA; Tzelepis F; Paul C
J Clin Nurs; 2019 Jun; 28(11-12):2296-2308. PubMed ID: 30791160
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania.
Swai AB; Lutale JL; McLarty DG
BMJ; 1993 Jun; 306(6892):1570-2. PubMed ID: 8329915
[TBL] [Abstract][Full Text] [Related]
14. Assessing need for pharmacist involvement to improve care coordination for patients on LAI antipsychotics transitioning from hospital to home: A work system approach.
Abraham O; Myers MN; Brothers AL; Montgomery J; Norman BA; Fabian T
Res Social Adm Pharm; 2017; 13(5):1004-1013. PubMed ID: 28811014
[TBL] [Abstract][Full Text] [Related]
15. "Experiences with disclosure of HIV-positive status to the infected child": Perspectives of healthcare providers in Dar es Salaam, Tanzania.
Sariah A; Rugemalila J; Somba M; Minja A; Makuchilo M; Tarimo E; Urassa D; Siril H
BMC Public Health; 2016 Oct; 16(1):1083. PubMed ID: 27737669
[TBL] [Abstract][Full Text] [Related]
16. The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.
James BO; Omoaregba JO; Okonoda KM; Otefe EU; Patel MX
Ther Adv Psychopharmacol; 2012 Oct; 2(5):169-77. PubMed ID: 23983972
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
18. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
Correll CU; Citrome L; Haddad PM; Lauriello J; Olfson M; Calloway SM; Kane JM
J Clin Psychiatry; 2016; 77(suppl 3):1-24. PubMed ID: 27732772
[TBL] [Abstract][Full Text] [Related]
19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
20. Long-acting injectable antipsychotics: evidence of effectiveness and use.
Manchanda R; Chue P; Malla A; Tibbo P; Roy MA; Williams R; Iyer S; Lutgens D; Banks N
Can J Psychiatry; 2013 May; 58(5 Suppl 1):5S-13S. PubMed ID: 23945067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
